AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,062.00p
   
  • Change Today:
      93.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,501.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.30m
  • Volume: 4,889,045
  • Market Cap: £155,992m
  • RiskGrade: 123
  • Beta: 0.87

AstraZeneca China president under investigation

By Iain Gilbert

Date: Wednesday 30 Oct 2024

LONDON (ShareCast) - (Sharecast News) - Drugmaker AstraZeneca revealed on Wednesday that Leon Wang, the president of AstraZeneca China, was under investigation by Chinese authorities.
AstraZeneca, which did not disclose whether or not Wang was currently in police custody, said he was "cooperating with an ongoing investigation".

The FTSE 100-listed group added that its China operations continued under the leadership of the current general manager of AstraZeneca China.

"If requested, AstraZeneca will fully cooperate with the investigation," added the group.

As of 1440 GMT, AstraZeneca shares were down 4.47% at 11,018.0p.





Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,062.00p
Change Today 93.00p
% Change 0.93 %
52 Week High 13,276.00p
52 Week Low 9,501.00p
Volume 4,889,045
Shares Issued 1,550.30m
Market Cap £155,992m
Beta 0.87
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
Income
78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

What The Brokers Say

Strong Buy 9
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-24 22-Feb-24
Paid 09-Sep-24 25-Mar-24
Amount 100.00¢ 197.00¢

Trades for 21-Nov-2024

Time Volume / Share Price
14:33 580,525 @ 9,867.00p
16:23 506,887 @ 9,866.30p
14:33 580,525 @ 9,867.00p
16:23 506,887 @ 9,867.00p
16:03 0 @ 10,030.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page